
The Future of Cancer Treatment: A Breakthrough Molecule Offers Hope for Head and Neck Cancers
Dr. Judy Sebolt-Leopold leads a revolution in targeted cancer therapies with MTX-531 at the University of Michigan. MTX-531 targets and inhibits EGFR and PI3K protein kinases, offering a more precise cancer treatment. The molecule’s “flipped binding mode” effectively tackles adaptive resistance and